Q3 2019 Holdings
Filed 2019-11-14 | 109 holdings | $374.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Avantor Inc(AVTR) | COM | 05352A100 | $88.2M | 6,000,000 | 23.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $79.6M | 650,000 | 21.3% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $75.3M | 450,000 | 20.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $56.3M | 700,000 | 15.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $22.8M | 200,000 | 6.1% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $14.4M | 150,000 | 3.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $13.0M | 400,000 | 3.5% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $6.2M | 500,000 | 1.7% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $4.6M | 150,000 | 1.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.3M | 200,000 | 1.1% |
| Alector Inc(ALEC) | COM | 014442107 | $3.2M | 225,000 | 0.9% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $2.7M | 100,000 | 0.7% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $1.7M | 425,000 | 0.4% |
| WW Intl Inc(WW6) | COM | 98262P101 | $560.4K | 14,818,300 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $181.3K | 60,240,864 | 0.0% |
| Bristol Myers Squibb Co(BMY)Call | COM | 110122108 | $177.5K | 3,500,000 | 0.0% |
| Bank Amer Corp(BAC)Call | COM | 060505104 | $87.5K | 3,000,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $73.3K | 4,606,298 | 0.0% |
| Medicines Co | COM | 584688105 | $70.0K | 1,400,000 | 0.0% |
| Morgan Stanley(MS)Call | COM NEW | 617446448 | $64.0K | 1,500,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $59.3K | 1,500,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $44.1K | 600,000 | 0.0% |
| Nvidia Corp(NVDA) | COM | 67066G104 | $34.8K | 200,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $32.9K | 1,819,186 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $31.1K | 2,000,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $27.0K | 1,608,968 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $22.2K | 2,833,791 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $21.2K | 1,500,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $21.0K | 150,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $21.0K | 2,346,040 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $20.1K | 2,500,000 | 0.0% |
| Zillow Group Inc(Z) | CL C CAP STK | 98954M200 | $19.4K | 650,000 | 0.0% |
| Spdr Series Trust(XBI)Call | S&P BIOTECH | 78464A870 | $19.1K | 250,000 | 0.0% |
| Incyte Corp(INCY)Call | COM | 45337C102 | $18.6K | 250,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $17.6K | 1,700,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $17.0K | 350,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $17.0K | 500,000 | 0.0% |
| Alibaba Group Hldg LTD(BABA)Call | SPONSORED ADS | 01609W102 | $16.7K | 100,000 | 0.0% |
| Cyclerion Therapeutics Inc(CYCNUSD) | COM | 23255M105 | $16.5K | 1,361,584 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $15.6K | 200,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $15.5K | 1,500,000 | 0.0% |
| Uber Technologies Inc(UBER) | COM | 90353T100 | $15.2K | 500,000 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $15.0K | 400,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $14.4K | 1,000,000 | 0.0% |
| American Airls Group Inc(AAL)Call | COM | 02376R102 | $13.5K | 500,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $12.7K | 700,000 | 0.0% |
| The Realreal Inc(REAL) | COM | 88339P101 | $12.6K | 565,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $11.1K | 360,000 | 0.0% |
| Nektar Therapeutics(NKTREUR)Call | COM | 640268108 | $10.9K | 600,000 | 0.0% |
| Stoneco LTD(STNE) | COM CL A | G85158106 | $10.4K | 300,000 | 0.0% |